ANSM Safety Alert: Atellica CH Urine Albumin Reagent
Summary
The French National Agency for Medicines and Health Products Safety (ANSM) has issued a safety alert regarding the Atellica CH Urine Albumin reagent from Siemens Healthcare Diagnostics Inc. The alert, registered under number R2602998, informs medical biology laboratories of a safety action implemented by the manufacturer.
What changed
The ANSM has issued a safety alert (Information R2602998) concerning the Atellica CH Urine Albumin reagent manufactured by Siemens Healthcare Diagnostics Inc. This alert informs medical biology laboratories that the manufacturer has implemented a safety action. The specific details of this action and the affected parties were communicated directly by Siemens Healthcare Diagnostics Inc. to the relevant users via a letter dated March 26, 2026.
Laboratories using this reagent should review the communication from Siemens Healthcare Diagnostics Inc. for specific instructions and actions required. The ANSM directs any questions regarding this safety action to the manufacturer. The document itself does not specify a compliance deadline or penalties, but implies that adherence to the manufacturer's safety action is expected.
What to do next
- Review safety action communication from Siemens Healthcare Diagnostics Inc.
- Contact Siemens Healthcare Diagnostics Inc. for any questions regarding the safety action.
Archived snapshot
Mar 26, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Information n° R2602998 destinée aux laboratoires d'analyses de biologie médicale L'ANSM a été informée de la mise en œuvre d’une action de sécurité effectuée par la société Siemens Healthcare Diagnostics Inc.
Les utilisateurs concernés ont reçu le courrier ci-joint.
Cette action de sécurité est enregistrée à l’ANSM sous le n° R2602998.
Pour toute question, merci de vous adresser directement à l’émetteur de l’action de sécurité. Consultez le courrier de la société Siemens Healthcare Diagnostics Inc. (26/03/2026)
Related changes
Get daily alerts for ANSM Drug & Device Safety Alerts
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from ANSM.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ANSM Drug & Device Safety Alerts publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.